• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

East Mediterr Health J . MERS-CoV in the COVID-19 era: update from Saudi Arabia, 2019-2020

tetano

Editor, Senior Moderator
East Mediterr Health J


. 2021 Dec 1;27(11):1109-1113.
doi: 10.26719/emhj.21.049.
MERS-CoV in the COVID-19 era: update from Saudi Arabia, 2019-2020


Anas Khan[SUP] 1 [/SUP], Sharafaldeen Bin Nafisah[SUP] 2 [/SUP], Bandr Mzahim[SUP] 2 [/SUP], Bakhitah Aleid[SUP] 3 [/SUP], Daliah Almatrafi[SUP] 2 [/SUP], Abdullah Assiri[SUP] 4 [/SUP], Hani Jokhdar[SUP] 4 [/SUP]



Affiliations

Abstract

in English, Arabic, French
Background: The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) infection during the period of coronavirus disease 2019 (COVID-19) remains uncertain.
Aims: This study aimed to provide an update on the epidemiology of MERS-CoV in Saudi Arabia from January 2019 to October 2020.
Methods: Data on all laboratory-confirmed cases of MERS-CoV infection in Saudi Arabia from January 2019 to 20 October 2020 were retrieved from the Health Electronic Surveillance Network of the Ministry of Health of Saudi Arabia. Data collected were: demographic characteristics of cases, clinical course of the infection, related mortality and association with exposure to confirmed cases or camels.
Results: In total, 299 cases of MERS-CoV infection were reported in the study period. The mean age of cases was 52.4 years. Most of the cases were males (78.9%) and had comorbidities (72.7%), and 11.9% of cases were health care providers. Of the 299 cases, 83 (27.7%) died. Older age and having comorbidities were associated with higher mortality. Exposure to camels was associated with lower mortality. Health care providers also had a lower mortality rate than non-health care providers. Compared with COVID-19, MERS-CoV infection still has a higher mortality rate but with a more predictable pattern and an anticipated deterioration.
Conclusion: MERS-CoV infection remains a public health concern. The percentage of cases that were health care providers (11.9%) is lower than previously reported (19.1-25.0%), possibly due to the various preventive measures put in place to control COVID-19.

Keywords: COVID-19; Middle East respiratory syndrome coronavirus; Saudi Arabia; health personnel; public health.
 
Back
Top Bottom